41. 巨細胞性動脈炎 Giant cell arteritis Clinical trials / Disease details

臨床試験数 : 128 / 薬物数 : 139 - (DrugBank : 36) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 124

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03745586 (ClinicalTrials.gov)	December 1, 2018	6/11/2018	Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab	Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab	Giant Cell Arteritis	Drug: Tocilizumab;Drug: Glucocorticoids	University Hospital Inselspital, Berne	NULL	Completed	50 Years	N/A	All	18	Phase 1/Phase 2	Switzerland;Italy
2	NCT01450137 (ClinicalTrials.gov)	September 2011	3/10/2011	Tocilizumab for Patients With Giant Cell Arteritis	A Phase II, Randomized, Double-blind, Placebo Controlled Study of Tocilizumab in Patients With Giant Cell Arteritis	Giant Cell Arteritis	Drug: Tocilizumab + Glucocorticoids (GCs);Drug: Placebo + Glucocorticoids (GCs)	University Hospital Inselspital, Berne	University of Bern;Roche Pharma AG	Completed	50 Years	N/A	All	30	Phase 2	Switzerland
3	NCT00004686 (ClinicalTrials.gov)	February 1994	24/2/2000	Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis		Giant Cell Arteritis	Drug: methotrexate;Drug: prednisone	The Cleveland Clinic	NULL	Completed	50 Years	N/A	Both	300	Phase 2	NULL